Avalanche (AVAX) Battles Market Downturn, Eyes $221 Target Despite Recent Setback
Avalanche (AVAX) faced a sharp decline recently, entering a “trublance” phase. Market turbulence followed the Federal Open Market Committee’s (FOMC) interest rate cuts, which initially seemed to bring relief. However, remarks from Federal Reserve Chair Jerome Powell sparked concerns. Powell’s projections for 2025 outlined fewer rate cuts than anticipated, creating ... Read more